1 / 3

Lenvima tablet

lenvima is used to treat a variety of cancer (small cell lung cancer, acute leukemia, bladder cancer) this medication is available in the form of injection in the strength of 100mg/5ml. Enquire about lenvima tablet.This anti-cancer medication is given under the supervision of a medical practitioner. <br>visit:https://www.magicinepharma.com/capsule/lenvima-lenvatinibs

15032
Download Presentation

Lenvima tablet

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lenvima tablet Overview Lenvima (Lenvatinib) is a medicine that is used to treat certain kinds of cancer (Thyroid cancer, Kidney cancer, and Liver cancer). This medicine belongs to a group of cancer-fighting medications known as antineoplastic. Take this medicine with or without food. Your doctor will decide the exact dosage. Do not take this medicine in the wrong way as it may lead to some severe side effects. If you experience any symptoms while receiving this medicine, inform your doctor immediately. It is advisable not to change or stop the dose without taking suggestions from your doctor. This medicine is not recommended for pregnant women.lenvima is used to treat a variety of cancer (small cell lung cancer, acute leukemia, bladder cancer) this medication is available in the form of injection in the strength of 100mg/5ml. Enquire about lenvima tablet.This anti-cancer medication is given under the supervision of a medical practitioner.

  2. Pharmacodynamics Of Lenvima (Lenvatinib) Lenvatinib is a receptor tyrosine kinase receptor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1, VEGFR2, VEGFR3. Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; the platelet-derived growth factor receptor alpha (PDGFRα), KIT, and RET. After the oral administration, the effect of this medicine can be observed in 1 to 4 hours.

More Related